Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ø¹ß¼º ´äÁó¼º °£°æº¯ÁõÀÇ ÀÓ»ó ¹× º´¸®ÇÐÀû °íÂû Clinical and Pathological Manifestations of Primary Biliary Cirrhosis

´ëÇѼÒÈ­±âÇÐȸÁö 2000³â 36±Ç 6È£ p.775 ~ 781
¼Ò¼Ó »ó¼¼Á¤º¸
¼­°æ´ö/Gyung Duk Seo ÀÌÀç½Â/ÀÌâÈÆ/¼Û°æÇÏ/ÀÌÁ¾ÈÆ/À̼º¿í/½Å¿ì¿ø/¹ÚÈñ½Â/°­´ëȯ/¼Û±Ù¾Ï/Á¶¸ù/¾ç¿õ¼®/Jae Seung Lee/Chang Hoon Lee/Gyung Ha Song/Jong Hoon Lee/Sung Wook Lee/Woo Won Shin/Hee Seung Park/Dae Hwan Kang/Geun Am Song/Mong Jo/Woong Suk Yang

Abstract

¸ñÀû :¿ø¹ß¼º ´ãÁó¼º °£°æº¯ÁõÀº ¿ì¸® ³ª¶ó¿¡¼­
´Â ¸Å¿ì µå¹® ÁúȯÀ¸·Î Áö±Ý±îÁö 28 ¿¹°¡ »ê¹ßÀûÀ¸
·Î º¸°íµÇ¾î ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚµéÀÌ °æÇèÇÑ 11 ¿¹¿¡ ´ë
ÇÑ ÀÓ»ó ¹× º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßÀ» °íÂûÇÏ¿´´Ù. ´ë»ó
¹× ¹æ¹ý :Ç×¹ÌÅäÄܵ帮¾Æ Ç×ü°¡ ¾ç¼ºÀÌ°í °£Á¶Á÷
°Ë»ç¿¡¼­ ¿ø¹ß¼º ´ãÁó¼º °£°æº¯Áõ¿¡ ÇÕ´çÇÑ ¼Ò°ßÀ»
º¸ÀÎ 11 ¿¹¸¦ ´ë»óÀ¸·Î ¿¬·É ¹× ¼ºº° ºÐÆ÷, ÀÓ»óÁõ»ó,
»ýÈ­ÇÐÀû °Ë»ç, ÀÚ°¡¸é¿ª Ç×ü, º´¸®Á¶Á÷ÇÐÀû ¼Ò°ß
µîÀ» ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. °á°ú :¿¬·ÉÀº 47.1 ¡¾
9.5 ¼¼ (³²ÀÚ 35.5 ¡¾0.5,¿©ÀÚ 49.7 ¡¾8.7 ¼¼ )¿´À¸¸ç ³²ÀÚ
°¡ 2 ¿¹ (18.2%),¿©ÀÚ°¡ 9 ¿¹ (81.8%)·Î ³²³à ºñ´Â
1:4.5 ¿´´Ù. ù ³»¿ø µ¿±â´Â ¿ì¿¬È÷ ¹ß°ßµÈ °£ ±â´É
ÀÌ»óÀÌ 4 ¿¹ (36.4%)·Î °¡Àå ¸¹¾Ò°í ¸¸¼º ÇǷΰ¨ 3 ¿¹
(27.3%),Ȳ´ÞÀ» µ¿¹ÝÇÑ ¼Ò¾çÁõ 3 ¿¹ (27.3%),Ȳ´Þ 1
¿¹ (9.0%)¼øÀ̾ú´Ù. »ýÈ­ÇÐÀû °Ë»ç·Î´Â alkaline
phosphatase ¿Í ¥ã-GTP ´Â ¸ðµç ¿¹¿¡¼­ ÇöÀúÈ÷ Áõ°¡
µÇ¾úÀ¸¸ç °¢°¢ 996.5 ¡¾449.0, 385.7 ¡¾202.3 IU/L ¿´
´Ù. AST ¿Í ALT Ä¡´Â °¢°¢ 183.5 ¡¾151.3, 166.9 ¡¾
144.1 IU/L ¿´´Ù. Ç÷û ÃѺô¸®·çºóÄ¡´Â 72.7% (8/11)
¿¡¼­ Áõ°¡µÇ¾úÀ¸¸ç Æò±ÕÄ¡´Â 4.7 ¡¾5.1 mg/dL ¿´°í,
ÃÑÄÝ·¹½ºÅ×·ÑÄ¡´Â 36.4% (4/11)¿¡¼­ Áõ°¡µÇ¾î ÀÖ¾ú
´Ù. IgM Ä¡´Â 87.5% (7/8)¿¡¼­ Áõ°¡µÇ¾ú°í Æò±ÕÄ¡´Â
581.0 ¡¾250.6 mg/dL ¿´´Ù. Ç×ÇÙ Ç×ü´Â 57.1% (4/7),
Ç×ÆòÈ°±Ù Ç×ü´Â 25.0% (2/8)¿¡¼­ ¾ç¼ºÀ̾ú´Ù. ³»½Ã
°æÀû ¿ªÇ༺ ´ã°üÁ¶¿µ¼ú ¶Ç´Â ÀÚ±â°ø¸í ´ã°üÁ¶¿µ¼ú
Àº 36.4% (4/11)¿¡¼­ °£³»´ã°üÀÌ °¡´Ã¾îÁø ¾ç»óÀ»
º¸¿´´Ù. °£»ý°Ë ¼Ò°ßÀ¸·Î´Â °£³»´ã°üÀÇ Æı« 10 ¿¹
(90 9%),´ã¼Ò°üÀÇ Áõ½Ä 9 ¿¹ (81.8%),¹®¸Æ¿ªÀÇ ¿°Áõ
¼¼Æ÷ ħÀ± 10 ¿¹ (90.9%),°£ ½ÇÁúÀÇ ¿°Áõ¼¼Æ÷ ħÀ±
5 ¿¹ (45.5%),°Ýº®ÀÇ ¼¶À¯È­ 6 ¿¹ (54.5%),°£°æº¯Áõ 4
¿¹ (36.4%)¿´´Ù. Mayo clinic prognostic index for-mula
¸¦ ÀÌ¿ëÇÏ¿© »ýÁ¸À²À» ¿¹ÃøÇÏ¿´À» ¶§ 7 ³â »ýÁ¸
°¡´É¼ºÀº 0.59-1.0 ±îÁö ºñ±³Àû ¾çÈ£ÇÑ ¿¹Èĸ¦ º¸¿´
´Ù. °á·Ð :ÀúÀÚµéÀÌ °æÇèÇÑ ¿ø¹ß¼º ´ãÁó¼º °£°æº¯Áõ
ÀÇ ÀÓ»óÀû Ư¡Àº ¼­±¸¿Í ºñ½ÁÇÏ¿´À¸³ª ù ³»¿ø µ¿
±â´Â ¼­±¸¿Í ´Þ¸® ¿ì¿¬È÷ ¹ß°ßµÈ °£±â´É ÀÌ»óÀÌ ¸¹
¾Ò°í, ¿¹ÈÄ´Â ºñ±³Àû ¾çÈ£ÇÏ¿´´Ù.
#ÃÊ·Ï#
Background/Aims: Primary biliary cirrhosis (PBC) is a rare disease in Korea and only 28 cases have been reported so far. We have experienced 11 cases of PBC and analyzed its clinical and histological features. Methods: We reviewed 11 patients
with
PBC
diagnosed by the presence of antimitochondrial antibody and pathologic findings of bile duct injury, retrospectively. Results: The mean age was 47.1¡¾9.5 years (male 35.5¡¾0.5, female 49.7¡¾8.7 years) and the male to female ratio was 1:4.5 (male
2/11,
female 9/11). The most common initial presentation was incidentally detected by abnormal results of liver function tests (36.4%). The laboratory findings revealed cholestatic pattern with markedly elevated levels of alkaline phosphatase
(996.5¡¾449.0
IU/L) and ¥ã-GTP (385.7¡¾202.3 IU/L) in all patients. Pathologic findings revealed: destruction of the intrahepatic bile ducts in 10 patients (90.9%), proliferation of bile ductules in 9 patients (81.8%), infiltration of inflammatory cellls in
portal
tracts in 10 patients (90.9%), infiltration of inflammatory cells in hepatic parenchyma in 5 patients (45.5%), septal fibrosis (scarring) in 6 patients (54.5%) and cirrhosis in 4 patients (36.4%). The 7-year-survival probability according to Mayo
Clinic
prognostic index formula is relatively good (0.59-1.0). Conclusions: The clinical characteristics of PBC are similar to those of western countries. However, the case in which initial presentation was incidentally detected by abnormal results of
liver
function tests was more common than in western countries.

Å°¿öµå

¿ø¹ß¼º ´ãÁó¼º °£°æº¯Áõ; ÀÓ»ó¾ç»ó; º´¸®¼Ò°ß; Primary biliary cirrhosis; Clinical manifestations; Pathologic findings;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS